Retina Associates of Kentucky
1 clinical trials · Sponsor
◉ Watch Retina Associates of Kentucky
| Record | Firm | Date |
|---|---|---|
| Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Ocular Histoplasmosis Syndrome (NCT00955630) | Retina Associates of Kentucky | 2009-08-01 |
Track Retina Associates of Kentucky automatically
Every clearance here is in the API, with alerts when new ones post.